Learn Why We Are the Largest and Most Successful Ophthalmology Clinical Trials Site in the US

Patients: Explore clinical trials across nearly every area of eye care. We’ll help you enroll in a trial that could improve your eye health, help others, and compensate you for your time.

Partners / Sponsors / CROs: Work with a trusted clinical trial site with 25 FDA approvals and nearly 500 completed sponsored, randomized trials—helping you enroll faster, generate high-quality data, and keep your trial on track.

Located Near Downtown Louisville, KY, in Butchertown

1536 Story Ave
Louisville, KY 40206
Call (502) 219-7700

Office hours:
Mon – Fri: 8 AM – 5 PM EST
Sat – Sun: Closed

FDA Approvals
Clinical Trials
Years of Principal Investigator Experience
Trialed Medical Conditions
bct building

About Butchertown Clinical Trials

Butchertown Clinical Trials is a clinical trials research site in Louisville, KY, specializing in ophthalmic, vaccine, adult medicine, and metabolic disease clinical trials. Our mission is to help improve treatments and access to innovative care for all patients by involving them in clinical trials. We regularly recruit study subjects for paid clinical trials sponsored by pharmaceutical companies and medical equipment firms to prove the usefulness of new treatments, surgical implants, or diagnostic medical devices.

How We Do Dry Eye Research and Paid Clinical Trials in Louisville, KY

We regularly recruit patients (study subjects) to enroll in dry eye research trials and paid clinical trials that are sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices.

dry eye research

We are always enrolling for our clinical research trials and studies for:

  • Dry Eye Disease
  • Cataract
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Corneal Dystrophy
  • Geographic Atrophy
  • LASIK and post-operative conditions
  • Conjunctivitis
  • Conditions of the Eye and Ocular Adnexa
  • Environmental Allergies
  • Seasonal Allergies
  • Presbyopia
  • Hypertension
  • Hypothyroid
  • High Cholesterol
  • Nutrition and Weight Loss
  • Type I and Type II Diabetes

New Posts From the Blog

We Have Been Named a Top Workplace in Kentucky

The Eye Care Institute, and our sister company, Butchertown Clinical Trials, proudly announce that we have been named a Top Workplace in Kentucky by the Kentucky Chamber of Commerce and Workforce Research Group. “Our ‘We Are The Yes Practice’ model emphasizes meeting patient expectations and offers a superior working environment to our employees. This is best achieved when patient needs…

Olivia Kaiser Promoted to Clinical Trials Site Manager

Olivia Kaiser, who began her career in clinical trials as a subject recruiter and was promoted to Clinical Trials Team Lead, has been promoted to Site Manager at Butchertown Clinical Trials. In Olivia’s new role, she will have expanded planning and trial coordination duties as the site is poised for additional growth and is currently undergoing an expansion allowing it…

You May Benefit By Participating in a Clinical Trial

Our Butchertown Clinical Trials division works with our doctors and patients to test new treatments, or variations of existing treatments, to determine if they are more effective, or safer than existing treatments, and therefore worthy of FDA approval. Under the direction of The Doctors of The Eye Care Institute, our clinical-trials-only staff of almost a dozen science-oriented individuals works to…

Taking A Weight Loss Drug and Worried About Vision Loss?

A recent study* was published showing an increase in eye disease, for those taking Semaglutide, GLP-1 Antagonist, for weight loss. Two of these three medications, Ozempic and Rybelsus, are FDA-approved for treating Type II Diabetes. These are often used “off-label” for weight loss. Wegovy is FDA-approved for those 12 and over to treat obesity. The increase in the incidence of…

Butchertown Clinical Trials and The Eye Care Institute Announce 21st FDA Approval

LOUISVILLE, KENTUCKY, UNITED STATES, March 11, 2024 /EINPresswire.com/ — Formosa Pharmaceuticals, Inc., Songshan Dist., Taipei City 105, Taiwan, announced the U.S. Food and Drug Administration (FDA) approved Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) for the treatment of ocular inflammation and pain following ocular surgery. Dr. Brennan P. Greene, MD. continued “Although much work remains to eradicate post-operative pain and inflammation, this…

Receive Announcements on Upcoming Research Trials

We regularly recruit patients (study subjects) to enroll in dry eye research trials and paid clinical trials that are sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices.

Get Started Today

We regularly recruit patients (study subjects) to enroll in clinical trials sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices. View open trials today.